Press

Positive results from Acarix study presented at ISPOR, a leading health economics conference

 

Acarix AB (publ) today announced that the company’s real-life data analysis, made in co-operation with clinics in Germany and Austria, is published as a poster presentation and abstract at ISPOR, the leading European conference for health economics and outcomes research, which is held virtually November 16-19, 2020.

PR_Acarix_ISPOR Eng

PM_Acarix_ISPOR SVE

 

 

 

 

 

 

About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.